Related Experiment Video
Updated: Jun 8, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
Cell death or survival promoted by alternative isoforms of ErbB4
Maria Sundvall1, Ville Veikkolainen, Kari Kurppa
1Department of Medical Biochemistry and Genetics, and Medicity Research Laboratory, University of Turku, Turku, Finland; Department of Oncology, Turku University Hospital, FIN-20520 Turku, Finland.
Abstract:
The significance of ErbB4 in tumor biology is poorly understood. The ERBB4 gene is alternatively spliced producing juxtamembrane (JM-a and JM-b) and cytoplasmic (CYT-1 and CYT-2) isoforms. Here, signaling via the two alternative ErbB4 JM isoforms (JM-a CYT-2 and JM-b CYT-2) was compared. Fibroblasts expressing ErbB4 JM-a demonstrated enhanced ErbB4 autophosphorylation, growth, and survival. In contrast, cells overexpressing ErbB4 JM-b underwent starvation-induced death. Both pro- and antisurvival responses to the two ErbB4 isoforms were sensitive to an ErbB kinase inhibitor. Platelet-derived growth factor receptor-alpha (PDGFRA) was identified as an ErbB4 target gene that was differentially regulated by the two ErbB4 isoforms. The soluble intracellular domain of ErbB4, released from the JM-a but not from the JM-b isoform, associated with the transcription factor AP-2 and promoted its potential to enhance PDGFRA transcription. Survival of cells expressing JM-a was suppressed by targeting either PDGFR-α or AP-2, whereas cells expressing JM-b were rescued from cell death by the PDGFR-α agonist, PDGF-BB. These findings indicate that two alternative ErbB4 isoforms may promote antagonistic cellular responses and suggest that pharmacological inhibition of ErbB4 kinase activity may lead to either suppression or promotion of cellular growth.
Insights
Two ErbB4 isoforms have opposite effects on cell growth and survival. ErbB4 JM-a promotes growth, while ErbB4 JM-b induces death, impacting tumor biology and ErbB4 inhibitor therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The role of ErbB4 in tumor biology remains unclear.
- The ERBB4 gene produces multiple isoforms through alternative splicing, including juxtamembrane (JM-a, JM-b) and cytoplasmic (CYT-1, CYT-2) variants.
Purpose of the Study:
- To compare signaling pathways mediated by two specific ErbB4 isoforms: JM-a CYT-2 and JM-b CYT-2.
- To investigate the differential regulation of target genes by these ErbB4 isoforms.
Main Methods:
- Comparative analysis of signaling via ErbB4 JM-a CYT-2 and JM-b CYT-2 isoforms in fibroblasts.
- Identification of ErbB4 target genes using molecular and cellular assays.
- Assessment of the role of Platelet-derived growth factor receptor-alpha (PDGFRA) and transcription factor AP-2 in ErbB4 isoform-mediated signaling.
Main Results:
- ErbB4 JM-a isoform expression enhanced ErbB4 autophosphorylation, cell growth, and survival.
- ErbB4 JM-b isoform overexpression led to starvation-induced cell death.
- Platelet-derived growth factor receptor-alpha (PDGFRA) was identified as a differentially regulated target gene, with its transcription influenced by the soluble intracellular domain of ErbB4 interacting with AP-2.
- JM-a isoform-mediated survival was dependent on PDGFR-α and AP-2, while JM-b isoform-induced cell death could be rescued by PDGF-BB.
Conclusions:
- The two alternative ErbB4 JM isoforms (JM-a and JM-b) can mediate opposing cellular responses, affecting cell survival and growth.
- These findings highlight the complexity of ErbB4 signaling in cancer.
- Pharmacological targeting of ErbB4 kinase activity may result in either promoting or inhibiting cellular growth, depending on the specific isoform involved.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Mitogens and the Cell Cycle
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Extrinsic Apoptotic Pathway
